Key result
Extended haplotypes in the growth hormone releasing hormone receptor (GHRHR) gene are significantly associated with normal variation in height, accounting for 1.8% of the variation and a decrease in height of 1.2 to 3.8 cm.
Observational (n=1,209)
p-value: p=0.00077
Extended haplotypes in the GHRHR gene are significantly associated with normal variation in human height, explaining up to 1.8% of the variance.
No clinical action indicated for height assessment; hypothesis-generating for GHRHR in growth genetics and requires replication.
Mutations in the gene for growth hormone releasing hormone receptor (GHRHR) cause isolated growth hormone deficiency (IGHD) but this gene has not been found to affect normal variation in height. We performed a whole genome linkage analysis for height in a population from northern Sweden and identified a region on chromosome 7 with a lod-score of 4.7. The GHRHR gene is located in this region and typing of tagSNPs identified a haplotype that is associated with height (p = 0.00077) in the original study population. Analysis of a sample from an independent population from the most northern part of Sweden also showed an association with height (p = 0.0039) but with another haplotype in the GHRHR gene. Both haplotypes span the 3' part of the GHRHR gene, including the region in which most of the mutations in IGHD have been located. The effect size of these haplotypes are larger than that of any gene previously associated with height, which indicates that GHRHR might be one of the most important genes so far identified affecting normal variation in human height.
No takes yet. Share an insight, caveat, or question.
Johansson et al. (2009) conducted an observational in Normal variation in height (n=1,209). Extended haplotypes in the GHRHR gene vs. Non-carriers of the haplotype was evaluated on Association with normal variation in height (p=0.00077). Extended haplotypes in the growth hormone releasing hormone receptor (GHRHR) gene are significantly associated with normal variation in height, accounting for 1.8% of the variation and a decrease in height of 1.2 to 3.8 cm.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: